Dallah Healthcare Co. announces its Interim Financial results for the Period Ending on 2026-06-30 ( Six Months )

The growth was primarily driven by an increase in patient visits to the Group's hospitals and medical centers. Total visits rose by 8.9%, reaching 1.037 million visits, compared to 953 thousand visits in the corresponding quarter of last year—an increase of approximately 85 thousand visits.

The rise in visits was recorded across geographies where the Group’s facilities exist. The Central Region accounted for 60.1% of the total increase in visits, while the Eastern Region contributed 30.3%, and the Western Region 9.6%. Revenue growth was also supported by an improved mix of medical services provided, alongside continued growth in specialized services.

With respect to newly acquired assets, Dallah Al Khobar Hospital and Dallah Al Ahsa Hospital achieved revenue growth of 22.5% in Q2-2026 compared to the same quarter of the previous year.

Earnings per share for the current quarter declined to SAR 0.99, compared to SAR 1.23 in the same quarter of the previous year. After excluding non recurring items, earnings per share for Q2-2026 rose by 3.5% to SAR 1.14, compared to SAR 1.10 in the corresponding quarter of the previous year—an increase of SAR 0.04 per share.

Looking at non recurring items, the second quarter of 2025 included a reversal of zakat provisions amounting to SAR 12.5 million following the closure of zakat assessments up to 2023. In contrast, the second quarter of 2026 incurred SAR 15.3 million in operating costs for the Mina Emergency Hospital in Makkah during the Hajj season. As a result, non recurring items had a net negative impact of SAR 27.8 million on the change in net profit for the current quarter compared to the same quarter of the previous year.

Despite this, the Company achieved revenue growth in Q2-2026 compared to the corresponding quarter of the previous year, supported by operational performance, which led to an increase of SAR 11.48 million in gross profit. Conversely, financing costs rose by SAR 6.9 million, mainly due to the financing burden associated with the Group’s acquisition program executed during 2025. It is worth noting that the Company will allocate the majority of the proceeds from the sale of its stake in Dr. Mohammed Rashed Al Faqih Company (an associate), of which an amount of SAR 466.7 million was received in July 2026, to reduce outstanding borrowings—an action expected to positively reflect on the financial statements of upcoming periods.

Net profit before financing costs, zakat, depreciation, and amortization (EBITDA) —adjusted for the impact of non recurring items—increased by 3.1% in Q2-2026 to SAR 236.6 million, compared to SAR 229.4 million in the same quarter of the previous year, representing an increase of SAR 7.2 million.

The growth was primarily driven by an increase in patient visits to the Group's hospitals and medical centers. Total visits rose by 10.4%, reaching 1.037 million visits, compared to 939 thousand visits in the previous quarter—an increase of approximately 98 thousand visits.

The rise in visits was recorded across geographies where the Group’s facilities exist. The Central Region accounted for 76.9% of the total increase in visits, while the Eastern Region contributed 22.8%, and the Western Region 0.3%.

Growth was primarily driven by the return of operational activity to higher levels following the month of Ramadan, despite the second quarter of 2026 being partially affected by the Eid Al Adha holiday period and the start of the summer vacation season.

With respect to newly acquired assets, Dallah Al Khobar Hospital and Dallah Al Ahsa Hospital recorded revenue growth of 15.6% in Q2-2026 compared to the previous quarter.

Earnings per share for the current quarter rose to SAR 0.99, compared to SAR 0.84 in the previous quarter. After excluding the non recurring item, earnings per share for Q2-2026 increased by 36.7% to SAR 1.14, compared to SAR 0.84 in the previous quarter—an increase of SAR 0.31 per share.

Regarding the non recurring item, the Company incurred SAR 15.3 million in operating costs for the Mina Emergency Hospital in Makkah during the Hajj season in Q2-2026.

The Company’s revenues grew in Q2-2026 compared to the previous quarter, supported by stronger operational activity. This growth was primarily driven by the return of operations to higher levels following the month of Ramadan, resulting in an increase in gross profit of SAR 53.28 million. This, in turn, contributed to an increase in operating profit of SAR 44.2 million, after excluding the impact of the non recurring cost related to operating the Mina Emergency Hospital.

Net profit before financing costs, zakat, depreciation, and amortization (EBITDA)—adjusted for the impact of the non recurring item—increased by 21.9% in Q2-2026 to SAR 236.6 million, compared to SAR 194.0 million in the previous quarter, representing an increase of SAR 42.6 million.

The growth was primarily driven by an increase in patient visits to the Group's hospitals and medical centers. Total visits rose by 17.2%, reaching 1.976 million visits, compared to 1.686 million visits in the same period of the previous year—an increase of approximately 290 thousand visits.

The rise in visits was recorded across geographies where the Group’s facilities exist. The Central Region accounted for 21.8% of the total increase in visits, while the Eastern Region contributed 73.8%, and the Western Region 4.4%. Revenue growth was also supported by an improved mix of medical services provided, alongside continued growth in specialized services.

With respect to newly acquired assets, Dallah Al‑Khobar Hospital and Dallah Al‑Ahsa Hospital achieved revenue growth of 112.2% during the current period of 2026 compared to the corresponding period of the previous year. It is worth noting that the revenues of both hospitals were consolidated into Dallah Health’s financials starting from March 23, 2025

Earnings per share for the current period decreased to SAR 1.83, compared to SAR 2.81 in the corresponding period of the previous year. After excluding non recurring items, earnings per share for the 2026 period declined by 8.9% to SAR 1.98, compared to SAR 2.17 in the corresponding period—reflecting a decrease of SAR 0.19 per share.

Regarding non recurring items, the 2025 period included a reversal of zakat provisions amounting to SAR 12.5 million following the closure of zakat assessments up to 2023, as well as the recognition of gains from participation in a real estate fund amounting to SAR 51.4 million. In contrast, the 2026 period incurred SAR 15.3 million in operating costs for the Mina Emergency Hospital during the Hajj season. Accordingly, non recurring items had a net negative impact of SAR 79.2 million on the change in net profit for the current period compared to the corresponding period of the previous year.

Despite this, the Company achieved revenue growth during H1-2026 compared to the corresponding period of the previous year, supported by operational performance, resulting in an increase in gross profit of SAR 47.95 million. Conversely, operating costs for the Group—after excluding non recurring costs—increased by SAR 44.5 million, largely due to the consolidation of operating expenses for Dallah Al Khobar Hospital and Dallah Al Ahsa Hospital into the Group’s financial statements beginning 23 March 2025. Financing costs also increased by SAR 24.06 million, primarily due to the consolidation of financing costs for both hospitals and the financing burden associated with the Group’s acquisition program.

It is worth noting that the Company will allocate the majority of the proceeds from the sale of its stake in Dr. Mohammed Rashed Al Faqih Company (an associate), of which an amount of SAR 466.7 million was received in July 2026, to reduce outstanding borrowings—an action expected to positively reflect on the financial statements of upcoming periods.

Net profit before financing costs, zakat, depreciation, and amortization (EBITDA)—adjusted for the impact of non recurring items—increased by 5.02% during the 2026 period to SAR 430.7 million, compared to SAR 410.1 million in the corresponding period of the previous year—an increase of SAR 20.6 million.